연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2927. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue
Soon-Chan Kim 1 2 3, Young-Eun Cho 1 2, Young-Kyoung Shin 1 2 3, Hyeon Jong Yu 4, Tamrin Chowdhury 4, Sojin Kim 4, Kyung Sik Yi 5, Chi-Hoon Choi 5 6, Sang-Hoon Cha 7 8, Chul-Kee Park 9, Ja-Lok Ku 10 11 12 13
Sci Data
. 2023 Jul 12;10(1):448.
Link
2926. The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma.
Park HJ, Choi JY, Kim BK, Hong KT, Kim HY, Kim IH, Cheon GJ, Cheon JE, Park SH, Kang HJ.
Children (Basel). 2023 Dec10(12):1936.
Link
2925. RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies.
Lee HY, Yang SB, Park MY, Baek GW, Kang HJ.
J Natl Cancer Inst. 2023 Oct115(10):1231-1233.
Link
2924. CD19 chimeric antigen receptor T cell therapy in leukemia xenograft mouse: Anti-leukemic efficacy, kinetics, and 4-week single-dose toxicity.
Kim JI, Park MY, Kwon E, Kang HJ, Kang BC.
Toxicol Appl Pharmacol. 2023 Sep475:116628.
Link
2923. Generation of antigen-specific T lymphocytes targeting Wilms tumor 1 using activated B cells.
Baek GW, Yun SO, Park MY, Kang HJ
Hum Immunol. 2023 Feb84(2):106-112.
Link
2922. Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data.
Koh KN, Han JW, Choi HS, Kang HJ, Lee JW, Yoo KH, Sung KW, Koo HH, Hong KT, Choi JY, Kang SH, Kim H, Im HJ, Hahn SM, Lyu CJ, Baek HJ, Kook H, Park KM, Yang EJ, Lim YT, Kim S, Lee JW, Chung NG, Cho B, Park M, Park HJ, Park BK, Lee JA, Park JE, Kim SK, Kim JY, Kim HS, Ma Y, Park KD, Park SK, Park ES, Shim YJ, Yoo ES, Ryu KH, Yoo JW, Lim YJ, Yoon HS, Lee MJ, Lee JM, Jeon IS, Jung HL, Chueh HW, Won S.
Cancer Res Treat. 2023 Jan55(1):279-290.
Link
2921. Prognostic significance of STING expression in solid tumor: a systematic review and meta-analysis
Younghoon Kim 1 2, Nam-Yun Cho 2, Lingyan Jin 2, Hye Yeong Jin 2 3, Gyeong Hoon Kang 2 3
Front Oncol
. 2023 Aug 29:13:1244962.
Link
2920. PAIP 2020: Microsatellite instability prediction in colorectal cancer
Kyungmo Kim 1, Kyoungbun Lee 2, Sungduk Cho 3, Dong Un Kang 4, Seongkeun Park 5, Yunsook Kang 5, Hyunjeong Kim 5, Gheeyoung Choe 6, Kyung Chul Moon 7, Kyu Sang Lee 6, Jeong Hwan Park 8, Choyeon Hong 2, Ramin Nateghi 9, Fattaneh Pourakpour 10, Xiyue Wang 11, Sen Yang 12, Seyed Alireza Fatemi Jahromi 13, Aliasghar Khani 13, Hwa-Rang Kim 14, Doo-Hyun Choi 14, Chang Hee Han 15, Jin Tae Kwak 16, Fan Zhang 17, Bing Han 17, David Joon Ho 18, Gyeong Hoon Kang 19, Se Young Chun 20, Won-Ki Jeong 21, Peom
Med Image Anal
. 2023 Oct:89:102886
Link
2919. Imaging of Indocyanine Green-Human Serum Albumin (ICG-HSA) Complex in Secreted Protein Acidic and Rich in Cysteine (SPARC)-Expressing Glioblastoma
Hye Jung Jang 1 2 3, Myung Geun Song 1 4, Cho Rong Park 1, Hyewon Youn 1 3 5, Yun-Sang Lee 1 2 3 6, Gi Jeong Cheon 1 3, Keon Wook Kang 1 2 3 4 6
Int J Mol Sci
. 2023 Jan 3;24(1):850.
Link
2918. Diagnostic performance improvement with combined use of proteomics biomarker assay and breast ultrasound
Su Min Ha # 1, Hong-Kyu Kim # 2, Yumi Kim 2 3, Dong-Young Noh 2 3, Wonshik Han 2 4, Jung Min Chang 5
Breast Cancer Res Treat. 2022 Apr;192(3):541-55
Link